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Background: Cutaneous leiomyosarcoma (CLM) is a very rare smooth muscle tumour that accounts for about
2–3% of all superficial soft tissue sarcomas. Although the development of various malignancies in scar tissue is well
known, we report the first case of a CLM developing in a small pox scar.
Case presentation: A 66-year-old man presented with a painless, slow-growing lump in a small pox scar on his left
shoulder. Histological biopsies showed the lesion to be a primary, well-differentiated cutaneous leiomyosarcoma. A
CT scan of the thorax was conducted, which showed no signs of metastases. The complete lesion was then
surgically excised, and histopathological examination revealed a radically excised cutaneous type leiomyosarcoma
After 13 months’ review the patient was doing well with no evidence of tumour recurrence.
Conclusions: This is the first report of a CLM arising in a small pox scar. Although the extended time interval
between scarring and malignant changes makes it difficult to advise strict follow-up for patients with small pox
scars, one should be aware that atypical changes and/or symptoms occurring in a small pox scar could potentially
mean malignant transformation.
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Cutaneous leiomyosarcoma (CLM) is a very rare smooth
muscle tumour that accounts for about 2–3% of all
superficial soft tissue sarcomas [1]. CLM presents in per-
sons of all ages but with a peak occurrence between 50–
70 years of age. It may occur anywhere on the body with
a predilection for the limbs. Clinical appearance of CLM
is non-specific with a wide range of differential diagno-
ses including squamous cell carcinoma, amelanotic mel-
anoma and basal cell carcinoma [2]. Although the
development of various malignancies in scar tissue is
well known, the highest association is found in chronic
burn scars. However, sarcomas develop very rarely in
(burn) scars. A case of a CLM developing in a small pox
scar is presented. To our knowledge, this is the first re-
port of such an association.* Correspondence: pol.chirurgie@gmail.com
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A 66-year-old man was referred to our outpatient clinic
by his dermatologist. He presented with a painless, slow-
growing lump in a small pox scar on his left shoulder
(Figure 1). Histological biopsies were taken and reviewed
by a specialised panel for soft tissue tumours, which
showed the lesion to be a primary, well-differentiated
cutaneous leiomyosarcoma. On re-examination, a firm,
nodular scar was seen with no signs of ulceration. There
was no lymphadenopathy in his axilla and/or neck. Add-
itionally, a CT scan of the thorax was conducted, which
showed no signs of metastases. The complete lesion was
then surgically excised and submitted for further patho-
logical examination (Figures 2 and 3). Histopathological
examination revealed a poorly delineated tumour located
in the dermis with nodular extension into the superficial
subcutis and showing a fasciculated growth pattern of
spindle cells with eosinophilic cytoplasm and hyperchro-
matic, elongated, blunt-ended and pleomorphic nuclei.
The mitotic index was less than 10/7 HPF (1.7 mm).
Neoplastic cells showed reactivity to α-smooth muscle
actin and desmin (Figure 4).. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Macroscopic view of the scar. The nodular aspect of the
small pox scar is clearly visible.
Figure 3 Histopathological features. Dermal proliferation of
elongated cells arranged in intersecting fascicles [hematoxylin &
eosin, original magnifications: (Figure 2) × 5; (Figure 3) × 20].
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were confirmed histologically. In conclusion, it concerned a
radically excised cutaneous type leiomyosarcoma, Coindre
type 1. At 13-month review, the patient was doing well with
no evidence of tumour recurrence. A control chest x-ray
after 6 and 12 months showed no evidence of metastases.
Discussion
CLM are very rare tumours. They typically present with
skin changes such as discolouration and ulceration, and
are generally small at presentation (1–2 cm). Due to
their low incidence and atypical presentation, they are
often misdiagnosed. The most effective treatment of
CLM is wide excision with a 3-5-cm lateral margin and
a depth that includes the subcutaneous tissue and fascia
[3,4]. Local excision without adequate margins leads to
recurrence, and increases the risk for metastatic and
possibly fatal disease.
Leiomyosarcoma of the skin can be classified as either
superficial (cutaneous or subcutaneous) or metastatic
leiomyosarcoma from a distant visceral site such as theFigure 2 Histopathological features. Dermal proliferation of
elongated cells arranged in intersecting fascicles [hematoxylin &
eosin, original magnifications: (Figure 2) × 5; (Figure 3) × 20].uterus or retroperitoneum [2]. Differentiation between
the cutaneous and subcutaneous subtypes is not always
straightforward, and the distinction is made on the basis
of different histological features and biological behaviour
[5]. As in our patient, CLM occurs most often on the ex-
tremities [6]. The metastatic potential differs signifi-
cantly between the histological subtypes, with the
cutaneous variant having a very low rate of distant me-
tastasis and a local recurrence rate of 30% [3]. In this
specific case, it also concerned a CLM and, because of
the clear surgical margins, has an excellent prognosis.
The aetiology of these tumours is relatively unknown,
although antecedent traumatic injury, ionising irradi-
ation, chemicals, sunlight and lupus vulgaris have been
associated with this type of tumour [7]. We here de-
scribe the first patient with CLM arising in a small pox
scar. There are various reports on CLM with a similar
association with scars [7-9]. The most common associ-
ation, however, is found in burn scars. The pathogenesis
of malignant transformation in burn scars is not known,Figure 4 Immunohistochemical stain for α-smooth muscle
actin: (Figure 4) × 10.
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reported in the literature [9].
Besides the occasional occurrence of CLM, a familial oc-
currence of cutaneous leiomyosarcoma with renal cancer
has been described in the context of hereditary cutaneous
leiomyomatosis and renal cell cancer (HLRCC) [10,11].
This rare inherited tumour syndrome is caused by germ
line mutations in the fumarate hydratase (FH) gene [12].
However, mutations in FH do not explain sporadic CLM
formation in scar tissue, since aberrant FH expression or
somatic mutations are not seen in sporadic tumours
[13,14]. Adjuvant therapies include radiation therapy,
chemotherapy and super voltage cobalt therapy, although
CLM has been reported to be both radio- and chemother-
apy resistant. [15]
Because this is the first report of a CLM arising in a
small pox scar, the presence of a common pathway to
malignant transformation with burn scars cannot be
determined. Although only a few risk factors have been
identified, the most obvious relation with scar tissue has
to be the antecedent traumatic injury. The extended
time interval between scarring and malignant changes
makes it difficult to advise strict follow-up for patients
with small pox scars. One should be aware however that
atypical changes and/or symptoms occurring in a small
pox scar could potentially mean malignant transform-
ation, and adequate diagnostic procedures such as local
biopsy and/or primary/secondary wide local excision are
the first appropriate steps.
Conclusions
This report describes the first case of CLM formation in
a small pox scar. Primary CLM can be a diagnostic chal-
lenge and adequate surgical excision is the appropriate
treatment. Based on this one case, regular checks cannot
be recommended. However, any change in the existing
scar should be followed by a biopsy in order to exclude
a sarcoma or make an early diagnosis.
Consent
Written informed consent was obtained from the patient
for publication of this report and accompanying images.
A copy of this written consent is available for review by
the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interest.
Author details
1Department of Surgery, University Medical Center Groningen, P.O. Box 30
001, Groningen, RB 9700, The Netherlands. 2Department of Pathology,
University Medical Center Groningen, University of Groningen, Groningen,
The Netherlands.
Authors’ contributions
RP and HD drafted the manuscript. JLR drafted part of the manuscript,
critically revised its final form, and provided Figures 2 and 3. RJG criticallyrevised the final manuscript and was responsible for the primary care and
outpatient controls. All authors read and approved the final manuscript.
Received: 14 April 2012 Accepted: 16 July 2012
Published: 16 July 2012
References
1. Zahm SH, Fraumeni JF Jr: The epidemiology of soft tissue sarcoma. Semin
Oncol 1997, 24:504–512.
2. Annest NM, Grekin SJ, Stone MS, Messingham MJ: Cutaneous
leiomyosarcoma: a tumour of he head and neck. Dermatol Surg 2007,
33:628–633.
3. Kuflik JH, Schwartz RA, Rothenberg J: Dermal leiomyosarcoma. J Am Acad
Dermatol 2003, 48:S51–S53.
4. Angeloni M, Muratori F, Magarelli N, Chalidis BE, Ricci R, Rossi B, Maccauro
G: Exophytic growth of a neglected giant subcutaneous leiomyosarcoma
of the lower extremity. A case report. Int Semin Surg Oncol 2008, 5:11.
5. Bernstein SC, Rienigk RK: Leiomyosarcoma of the skin. Treatment of 34
cases. Dermatol Surg 1996, 22:631–635.
6. Liao WC, Lin JT, Ma H, Chen WYK, Yeh FL: Primary cutaneous
leiomyosarcoma. J Plast Surg Assoc ROC 2003, 12(1):1–10.
7. Gonzales-Sixto B, De la Torre C, Parvadilla R, Carpintero ML:
Leiomyosarcoma arising from scofuloderma scar. Clin Exp Dermatol 2008,
33:776–778.
8. Conzales-Vela MC, Val=Bernal JF, Rubio S, Olalla JJ, Gonzales-Lopez MA:
Cutaneous leiomyosarcoma developing on a pacemaker pocket.
Dermatol Surg 2009, 35:863–867.
9. Can Z, Yilmaz S, Riza A, Erocen, Apaydin I, Kuzu I: Sarcoma developing in a
burn scar: case report and review of the literature. Burns 1998, 24:68–71.
10. Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart
L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther
MM, Linehan WM, Schmidt LS, Zbar B: Mutations in the fumarate
hydratase gene cause hereditary leiomyomatosis and renal cell cancer in
families in North America. Am J Hum Genet 2003, 73:95–106.
11. Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P,
Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan
WM, Toro JR: Novel mutations in FH and expansion of the spectrum of
phenotypes expressed in families with hereditary leiomyomatosis and
renal cell cancer. J Med Genet 2006, 43:18–27.
12. Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I,
Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K,
Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P,
Eklund C, Vierimaa O, Aittomäki K, Hietala M, Sistonen P, Paetau A, Salovaara
R, Herva R, Launonen V, et al: Germ line mutations in FH predispose to
dominantly inherited uterine fibroids, skin leiomyomata and papillary
renal cell cancer. Nat Genet 2002, 30:406–410.
13. Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M,
Manyonda I, Houlston RS: No evidence for epigenetic inactivation of
fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett
2006, 235:136–140.
14. Barker KT, Bevan S, Wang R, Lu YJ, Flanagan AM, Bridge JA: Low frequency
of somatic mutations in the FH/multiple cutaneous leiomyomatosis
gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer
2002, 87(4):446–448.
15. Lin JY, Tsai RY: Subcutaneous leiomyosarcoma on the face. Dermatol Surg
1999, 25:489–491.
doi:10.1186/1477-7819-10-148
Cite this article as: Pol et al.: Cutaneous leiomyosarcoma arising in a
smallpox scar. World Journal of Surgical Oncology 2012 10:148.
